Partner
Stonehaven Cozmix Group (SC Group)

Beatrice Vos is a partner at the Stonehaven Cozmix Group and leads Stonehaven Transactions, providing end-to-end services in animal health transactions. She brings 20+ years of experience in M&A and other business development transactions. Before joining Stonehaven, she led Elanco’s international legal team and acted as lead counsel in many of Elanco’s key BD deals. She started her career as M&A lawyer with international law firms Freshfields and Allen & Overy.

Other speakers

Sven Arnouts Business Development Manager Ghent University - Provaxs
Klaus Hellmann Chief Veterinary Officer Argenta
Johannes Charlier Managing Director Kreavet
Nathalie Vanderheijden Coordinator fot the European Partnership on Animal Health and Welfare Ghent University
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer-Ingelheim Animal Health
Sebastiaan Theuns CEO & co-founder PathoSense
Dieter Vancraeynest External Innovation Zoetis
Bryan Charleston Director and CEO The Pirbright Institute
Stewart Burgess Head of Department of Vaccines & Diagnostics Moredun Research Institute
Inne Xhonneux Project Advisor Life Sciences Flanders Innovation & Entrepreneurship (VLAIO)
Kazuhiko Hirose President and Representative Director Meiji Animal Health Co., Ltd.
Hanjo Hennemann Co-founder and CEO Verovaccines
Juerg Baggenstoss Partner Stonehaven Cozmix Group
Paul Dick Founder and President Paul Dick and Associates
Steve Nanchen Head External Innovation - R&D Elanco Animal Health
Erwin Blomsma CEO and Co-Founder Virovet
Alfonso Martín-Fontecha Business Development Manager Laboratorios SYVA
Valerio Abbadessa Research Programme Officer EC DG AGRI, F2 R&I
Paul Horwood UK Head of Farm & Exports IVC Evidensia
Daisy Vanrompay Director of the Laboratory of Immunology and Animal Biotechnology Ghent University
Jennifer Serriere-Di Bartolo Biopharma Strategic Collaboration & Marketing Manager Promega
Jens Radzimanowski Director of Antibody Therapeutics Lead Identification Boehringer Ingelheim
Pieter-Jan Serreyn Technical Director AnimalhealthEurope
Charles Owen Founder and CEO 272Bio Limited
Jeremy Gowler Chief Executive Officer Ophirex, Inc.
Ralf Herold Head of Regulatory Science and Academia, Task force Regulatory Science and Innovation, EMA European Medicines Agency

Registrations are now open